Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Ipca Laboratories has informed that it enclosed the transcript of the Conference Call held on Friday, 6th August, 2021 to discuss the Company's 01 FY22 earnings and business update.
The above information is a part of company’s filings submitted to BSE.